Effects of Bile Acids on Neurological Function and Disease

Overview

Journal FASEB J

Specialties Biology
Physiology

Date 2016 Jul 30

PMID 27468758

Citations 81

Authors

Matthew McMillin

Sharon DeMorrow

Affiliations

Soon will be listed here.

Abstract

Bile acids are synthesized from cholesterol and are known to be involved with the emulsification and digestion of dietary lipids and fat-soluble vitamins. Outside of this role, bile acids can act as cell signaling effectors through binding and activating receptors on both the cell membrane and nucleus. Numerous reports have investigated these signaling pathways in conditions where the liver is damaged. More recently, effort has been made to investigate the role of bile acids in diseases outside of those associated with liver damage. This review summarizes recent findings on the influences that bile acids can exert in normal neurological function and their contribution to diseases of the nervous system, with the intent of highlighting the role of these metabolites as potential players in neurological disorders.-McMillin, M., DeMorrow, S. Effects of bile acids on neurological function and disease.

Citing Articles

Unraveling the Role of the Human Gut Microbiome in Health and Diseases.

Khalil M, Di Ciaula A, Mahdi L, Jaber N, Di Palo D, Graziani A Microorganisms. 2024; 12(11).

PMID: 39597722 PMC: 11596745. DOI: 10.3390/microorganisms12112333.

Bidirectional Mendelian randomization links gut microbiota to primary biliary cholangitis.

Zhou Z, Li W, Wu Y, Wang T, Zhang J, You L Sci Rep. 2024; 14(1):28301.

PMID: 39550468 PMC: 11569131. DOI: 10.1038/s41598-024-79227-z.

Fecal bile acid dysmetabolism and reduced ursodeoxycholic acid correlate with novel microbial signatures in feline chronic kidney disease.

Rowe J, Summers S, Quimby J, Winston J Front Microbiol. 2024; 15:1458090.

PMID: 39498133 PMC: 11532117. DOI: 10.3389/fmicb.2024.1458090.

Bile acid modulation by gut microbiota: a bridge to understanding cognitive health.

Sabahat S, Saqib M, Talib M, Shaikh T, Khan T, Kailash S Ann Med Surg (Lond). 2024; 86(9):5410-5415.

PMID: 39239005 PMC: 11374218. DOI: 10.1097/MS9.0000000000002433.

New insights into potential biomarkers and their roles in biological processes associated with hepatitis C-related liver cirrhosis by hepatic RNA-seq-based transcriptome profiling.

Nasr Azadani H, Toosi M, Shahmahmoodi S, Nejati A, Rahimi H, Farahmand M Virus Res. 2024; 349:199457.

PMID: 39216827 PMC: 11415974. DOI: 10.1016/j.virusres.2024.199457.

References

Dionisio P, Amaral J, Ribeiro M, Lo A, DHooge R, Rodrigues C . Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. Neurobiol Aging. 2014; 36(1):228-40. DOI: 10.1016/j.neurobiolaging.2014.08.034. View

Kotti T, Ramirez D, Pfeiffer B, Huber K, Russell D . Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci U S A. 2006; 103(10):3869-74. PMC: 1450160. DOI: 10.1073/pnas.0600316103. View

Calkin A, Tontonoz P . Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol. 2012; 13(4):213-24. PMC: 3597092. DOI: 10.1038/nrm3312. View

Ho P, Steinman L . Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2016; 113(6):1600-5. PMC: 4760777. DOI: 10.1073/pnas.1524890113. View

Raghupathi R, Graham D, McIntosh T . Apoptosis after traumatic brain injury. J Neurotrauma. 2000; 17(10):927-38. DOI: 10.1089/neu.2000.17.927. View

Mano N, Goto T, Uchida M, Nishimura K, Ando M, Kobayashi N . Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain. J Lipid Res. 2003; 45(2):295-300. DOI: 10.1194/jlr.M300369-JLR200. View

Takigawa T, Miyazaki H, Kinoshita M, Kawarabayashi N, Nishiyama K, Hatsuse K . Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice. Am J Physiol Gastrointest Liver Physiol. 2013; 305(6):G427-38. DOI: 10.1152/ajpgi.00205.2012. View

Selkoe D, Hardy J . The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016; 8(6):595-608. PMC: 4888851. DOI: 10.15252/emmm.201606210. View

Bonifati V . Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics. Eur J Hum Genet. 2006; 14(10):1061-2. DOI: 10.1038/sj.ejhg.5201695. View

10.

Durk M, Han K, Chow E, Ahrens R, Henderson J, Fraser P . 1α,25-Dihydroxyvitamin D3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer's disease. J Neurosci. 2014; 34(21):7091-101. PMC: 6608194. DOI: 10.1523/JNEUROSCI.2711-13.2014. View

11.

Dawson P . Role of the intestinal bile acid transporters in bile acid and drug disposition. Handb Exp Pharmacol. 2010; (201):169-203. PMC: 3249407. DOI: 10.1007/978-3-642-14541-4_4. View

12.

Ding L, Yang L, Wang Z, Huang W . Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 2015; 5(2):135-44. PMC: 4629217. DOI: 10.1016/j.apsb.2015.01.004. View

13.

L Bookout A, Jeong Y, Downes M, Yu R, Evans R, Mangelsdorf D . Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell. 2006; 126(4):789-99. PMC: 6211849. DOI: 10.1016/j.cell.2006.06.049. View

14.

Jurutka P, Thompson P, Whitfield G, Eichhorst K, Hall N, Dominguez C . Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4. J Cell Biochem. 2004; 94(5):917-43. DOI: 10.1002/jcb.20359. View

15.

Wang H, Chen J, HOLLISTER K, Sowers L, Forman B . Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell. 1999; 3(5):543-53. DOI: 10.1016/s1097-2765(00)80348-2. View

16.

Vassileva G, Golovko A, Markowitz L, Abbondanzo S, Zeng M, Yang S . Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem J. 2006; 398(3):423-30. PMC: 1559456. DOI: 10.1042/BJ20060537. View

17.

Uno Y, Hosaka S, Yamazaki H . Identification and analysis of CYP7A1, CYP17A1, CYP20A1, CYP27A1 and CYP51A1 in cynomolgus macaques. J Vet Med Sci. 2015; 76(12):1647-50. PMC: 4300383. DOI: 10.1292/jvms.14-0313. View

18.

Gaspar J, Martins A, Cruz R, Rodrigues C, Ambrosio A, Santiago A . Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose. Neuroscience. 2013; 253:380-8. DOI: 10.1016/j.neuroscience.2013.08.053. View

19.

Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A . Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis. 2006; 23(2):329-41. DOI: 10.1016/j.nbd.2006.04.001. View

20.

Beilke L, Aleksunes L, Holland R, Besselsen D, Beger R, Klaassen C . Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice. Drug Metab Dispos. 2009; 37(5):1035-45. PMC: 2683394. DOI: 10.1124/dmd.108.023317. View